These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35106126)

  • 41. Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy.
    Gallagher JR; McCraw DM; Torian U; Gulati NM; Myers ML; Conlon MT; Harris AK
    Vaccines (Basel); 2018 May; 6(2):. PubMed ID: 29799445
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heterologous prime-boost vaccination with MF59-adjuvanted H5 vaccines promotes antibody affinity maturation towards the hemagglutinin HA1 domain and broad H5N1 cross-clade neutralization.
    Khurana S; Coyle EM; Dimitrova M; Castellino F; Nicholson K; Del Giudice G; Golding H
    PLoS One; 2014; 9(4):e95496. PubMed ID: 24755693
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines.
    Khurana S; Larkin C; Verma S; Joshi MB; Fontana J; Steven AC; King LR; Manischewitz J; McCormick W; Gupta RK; Golding H
    Vaccine; 2011 Aug; 29(34):5657-65. PubMed ID: 21704111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune Evaluation of Recombinant
    Niu H; Xing JH; Zou BS; Shi CW; Huang HB; Jiang YL; Wang JZ; Cao X; Wang N; Zeng Y; Yang WT; Yang GL; Wang CF
    Front Immunol; 2021; 12():800965. PubMed ID: 34925386
    [No Abstract]   [Full Text] [Related]  

  • 45. Influenza Viral Vectors Expressing Two Kinds of HA Proteins as Bivalent Vaccine Against Highly Pathogenic Avian Influenza Viruses of Clade 2.3.4.4 H5 and H7N9.
    Li J; Hou G; Wang Y; Wang S; Peng C; Yu X; Jiang W
    Front Microbiol; 2018; 9():604. PubMed ID: 29670587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages.
    Corbett KS; Moin SM; Yassine HM; Cagigi A; Kanekiyo M; Boyoglu-Barnum S; Myers SI; Tsybovsky Y; Wheatley AK; Schramm CA; Gillespie RA; Shi W; Wang L; Zhang Y; Andrews SF; Joyce MG; Crank MC; Douek DC; McDermott AB; Mascola JR; Graham BS; Boyington JC
    mBio; 2019 Feb; 10(1):. PubMed ID: 30808695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization and Immunogenicity of Influenza H7N9 Vaccine Antigens Produced Using a Serum-Free Suspension MDCK Cell-Based Platform.
    Chia MY; Lin CY; Chen PL; Lai CC; Weng TC; Sung WC; Hu AY; Lee MS
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of the Hemagglutinin Residue 227 in Immunogenicity of H5 and H7 Subtype Avian Influenza Vaccines in Chickens.
    Hu Z; Shi L; Zhao J; Gu H; Hu J; Wang X; Liu X; Hu S; Gu M; Cao Y; Liu X
    Avian Dis; 2020 Dec; 64(4):445-450. PubMed ID: 33347548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
    Lei H; Peng X; Jiao H; Zhao D; Ouyang J
    Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A combination vaccine against SARS-CoV-2 and H1N1 influenza based on receptor binding domain trimerized by six-helix bundle fusion core.
    Shi R; Zeng J; Xu L; Wang F; Duan X; Wang Y; Wu Z; Yu D; Huang Q; Yao YG; Yan J
    EBioMedicine; 2022 Nov; 85():104297. PubMed ID: 36206623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intermonomer Interactions in Hemagglutinin Subunits HA1 and HA2 Affecting Hemagglutinin Stability and Influenza Virus Infectivity.
    Wang W; DeFeo CJ; Alvarado-Facundo E; Vassell R; Weiss CD
    J Virol; 2015 Oct; 89(20):10602-11. PubMed ID: 26269180
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity.
    Li ZN; Mueller SN; Ye L; Bu Z; Yang C; Ahmed R; Steinhauer DA
    J Virol; 2005 Aug; 79(15):10003-12. PubMed ID: 16014960
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Designed nanoparticles elicit cross-reactive antibody responses to conserved influenza virus hemagglutinin stem epitopes.
    McCraw DM; Myers ML; Gulati NM; Prabhakaran M; Brand J; Andrews S; Gallagher JR; Maldonado-Puga S; Kim AJ; Torian U; Syeda H; Boyoglu-Barnum S; Kanekiyo M; McDermott AB; Harris AK
    PLoS Pathog; 2023 Aug; 19(8):e1011514. PubMed ID: 37639457
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intranasal vaccination of recombinant H5N1 HA1 proteins fused with foldon and Fc induces strong mucosal immune responses with neutralizing activity: Implication for developing novel mucosal influenza vaccines.
    Yu F; Li Y; Guo Y; Wang L; Yang J; Zhao G; Zhou Y; Du L; Jiang S
    Hum Vaccin Immunother; 2015; 11(12):2831-8. PubMed ID: 26260706
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.
    Russ G; Poláková K; Kostolanský F; Styk B; Vancíková M
    Acta Virol; 1987 Sep; 31(5):374-86. PubMed ID: 2891276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recombinant HA1-ΔfliC enhances adherence to respiratory epithelial cells and promotes the superiorly protective immune responses against H9N2 influenza virus in chickens.
    Wang T; Wei F; Liu L; Sun Y; Song J; Wang M; Yang J; Li C; Liu J
    Vet Microbiol; 2021 Nov; 262():109238. PubMed ID: 34560407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contributions of HA1 and HA2 Subunits of Highly Pathogenic Avian Influenza Virus in Induction of Neutralizing Antibodies and Protection in Chickens.
    Shirvani E; Paldurai A; Varghese BP; Samal SK
    Front Microbiol; 2020; 11():1085. PubMed ID: 32582071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diversity of the class II (I-Ak/I-Ek)-restricted T cell repertoire for influenza hemagglutinin and antigenic drift. Six nonoverlapping epitopes on the HA1 subunit are defined by synthetic peptides.
    Burt DS; Mills KH; Skehel JJ; Thomas DB
    J Exp Med; 1989 Aug; 170(2):383-97. PubMed ID: 2474053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of HA1 antigen of H5N1 influenza virus as a potent candidate for vaccine in bacterial system.
    Farsad AS; Malekzadeh-Shafaroudi S; Moshtaghi N; Fotouhi F; Zibaee S
    Iran J Vet Res; 2016; 17(4):237-242. PubMed ID: 28224006
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunogenicity and protective efficacy of a dual subunit vaccine against respiratory syncytial virus and influenza virus.
    Park MH; Chang J
    Immune Netw; 2012 Dec; 12(6):261-8. PubMed ID: 23396871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.